$ONMD
OneMedNet Corp Stock $onmd

$onmd Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000141057823000553 Filed on March 31, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue		$1.513M
YoY Change
Gross Profit		-$360.7K
YoY Change
Gross Profit Margin
Selling, General & Admin	$52.76K	$205.6K
YoY Change	-67.83%	25.33%
% of Gross Profit
Research & Development		$952.7K
YoY Change
% of Gross Profit
Depreciation & Amortization		$24.81K
YoY Change
% of Gross Profit
Operating Expenses	$3.385M	$5.309M
YoY Change	714.9%	806.94%
Operating Profit		-$5.309M
YoY Change
Interest Expense	$592.0K	$1.372M
YoY Change	2999.37%	6441.2%
% of Operating Profit
Other Income/Expense, Net	$245.2K	$4.489M
YoY Change	-459.35%	-21.25%
Pretax Income	-$2.547M	$551.5K
YoY Change	448.44%	-89.26%
Income Tax	$108.1K	$214.9K
% Of Pretax Income		38.96%
Net Earnings	-$2.656M	$336.7K
YoY Change	471.72%	-93.44%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.22	$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.87K	$30.87K
YoY Change	-93.19%	-93.19%
Cash & Equivalents	$30.87K
Short-Term Investments		$29.03M
Other Short-Term Assets	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Inventory
Prepaid Expenses
Receivables	$18.98K	$18.98K
Other Receivables	$900.2K	$900.2K
Total Short-Term Assets	$30.87K	$30.87K
YoY Change	-94.24%	-94.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$83.10K	$83.10K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$29.03M	$29.03M
YoY Change	-75.26%	-75.26%
Other Assets
YoY Change
Total Long-Term Assets	$29.03M	$29.03M
YoY Change	-75.26%	-75.26%
TOTAL ASSETS
Total Short-Term Assets	$30.87K	$30.87K
Total Long-Term Assets	$29.03M	$29.03M
Total Assets	$29.06M	$29.06M
YoY Change	-75.34%	-75.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$2.815M
YoY Change
Accrued Expenses	$1.750M	$1.750M
YoY Change	1289.05%	1289.05%
Deferred Revenue
YoY Change
Short-Term Debt	$11.50K	$11.50K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.976M	$1.976M
YoY Change	581.47%	581.47%
LONG-TERM LIABILITIES
Long-Term Debt	$2.753M	$2.753M
YoY Change
Other Long-Term Liabilities	$4.388M	$4.388M
YoY Change	-50.57%	-50.57%
Total Long-Term Liabilities	$7.140M	$7.140M
YoY Change	-19.56%	-19.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.976M	$1.976M
Total Long-Term Liabilities	$7.140M	$7.140M
Total Liabilities	$9.117M	$9.117M
YoY Change	-0.55%	-0.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.63M
YoY Change	35.11%
Common Stock	$455.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.806M	$19.94M
YoY Change
Total Liabilities & Shareholders Equity	$29.06M	$29.06M
YoY Change	-75.34%	-75.34%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.656M	$336.7K
YoY Change	471.72%	-93.44%
Depreciation, Depletion And Amortization		$24.81K
YoY Change
Cash From Operating Activities	-$143.9K	-$940.5K
YoY Change	78.65%	148.48%
INVESTING ACTIVITIES
Capital Expenditures		$58.14K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$213.0K	-$2.246M
YoY Change		-98.09%
Cash From Investing Activities	-$213.0K	-$2.246M
YoY Change		-98.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	152.9K	2.764M
YoY Change		-97.66%
NET CHANGE
Cash From Operating Activities	-143.9K	-940.5K
Cash From Investing Activities	-213.0K	-2.246M
Cash From Financing Activities	152.9K	2.764M
Net Change In Cash	-204.0K	-422.3K
YoY Change	153.29%	-193.19%
FREE CASH FLOW
Cash From Operating Activities	-$143.9K	-$940.5K
Capital Expenditures		$58.14K
Free Cash Flow		-$998.6K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001849380
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dkdcu	Transition Report TransitionReport	false
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40386
CY2022	dei	Entity Registrant Name EntityRegistrantName	Data Knights Acquisition Corp.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2076743
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Unit G6, Frome Business Park, Manor Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Frome
CY2022	dei	Entity Address Country EntityAddressCountry	GB
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	BA11 4FN
CY2022	dei	City Area Code CityAreaCode	011
CY2022	dei	Local Phone Number LocalPhoneNumber	44 203 833 4000
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	113735000
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	Boston, MA
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30870
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	453151
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21215
CY2021Q4	dkdcu	Prepaid Insurance Current PrepaidInsuranceCurrent	61846
CY2022Q4	us-gaap	Assets Current AssetsCurrent	30870
CY2021Q4	us-gaap	Assets Current AssetsCurrent	536212
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	29029416
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	117320973
CY2022Q4	us-gaap	Assets Assets	29060286
CY2021Q4	us-gaap	Assets Assets	117857185
CY2022Q4	dkdcu	Accrued Liabilities Excluding Offering Costs Current AccruedLiabilitiesExcludingOfferingCostsCurrent	1679821
CY2021Q4	dkdcu	Accrued Liabilities Excluding Offering Costs Current AccruedLiabilitiesExcludingOfferingCostsCurrent	125972
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	11500
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	214850
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	69966
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	164008
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1976137
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	289980
CY2022Q4	dkdcu	Warrant Liability Non Current WarrantLiabilityNonCurrent	362558
CY2021Q4	dkdcu	Warrant Liability Non Current WarrantLiabilityNonCurrent	4851668
CY2022Q4	dkdcu	Deferred Offering Costs Non Current DeferredOfferingCostsNonCurrent	4025000
CY2021Q4	dkdcu	Deferred Offering Costs Non Current DeferredOfferingCostsNonCurrent	4025000
CY2022Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	207081
CY2022Q4	dkdcu	Extension Loans Non Current ExtensionLoansNonCurrent	2545838
CY2022Q4	us-gaap	Liabilities Liabilities	9116614
CY2021Q4	us-gaap	Liabilities Liabilities	9166648
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-378487
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2825823
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11632745
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8609810
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8806438
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8609463
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29060286
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	117857185
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5103731
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	421397
CY2022	dkdcu	Franchise Tax Expense FranchiseTaxExpense	205560
	dkdcu	Franchise Tax Expense FranchiseTaxExpense	164008
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5309291
	us-gaap	Operating Income Loss OperatingIncomeLoss	-585405
	dkdcu	Interest Earned On Marketable Securities Held In Trust Account InterestEarnedOnMarketableSecuritiesHeldInTrustAccount	1876
CY2022	dkdcu	Realized And Unrealized Gain Loss RealizedAndUnrealizedGainLoss	1371689
	dkdcu	Realized And Unrealized Gain Loss RealizedAndUnrealizedGainLoss	19097
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4489110
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6325281
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-625059
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	551508
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5135790
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	214850
CY2022	us-gaap	Net Income Loss NetIncomeLoss	336658
	us-gaap	Net Income Loss NetIncomeLoss	5135790
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8609463
CY2022	dkdcu	Common Stock Subject To Possible Redemption Value CommonStockSubjectToPossibleRedemptionValue	3359593
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2825960
CY2022	us-gaap	Net Income Loss NetIncomeLoss	336658
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8806438
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	0
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000
	dkdcu	Sale Of Non Redeemable Private Placement Units To Sponsor SaleOfNonRedeemablePrivatePlacementUnitsToSponsor	5290301
	dkdcu	Common Stock Subject To Possible Redemption Value CommonStockSubjectToPossibleRedemptionValue	19060554
	us-gaap	Net Income Loss NetIncomeLoss	5135790
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8609463
CY2022	us-gaap	Profit Loss ProfitLoss	336658
	us-gaap	Profit Loss ProfitLoss	5135790
	dkdcu	Offering Costs Allocated To Warrant Liability OfferingCostsAllocatedToWarrantLiability	625059
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2825960
	us-gaap	Share Based Compensation ShareBasedCompensation	0
CY2022	dkdcu	Realized And Unrealized Gain Loss RealizedAndUnrealizedGainLoss	1371689
	dkdcu	Realized And Unrealized Gain Loss RealizedAndUnrealizedGainLoss	19097
	dkdcu	Interest Earned On Marketable Securities Held In Trust Account InterestEarnedOnMarketableSecuritiesHeldInTrustAccount	1876
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4489110
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6325281
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-83061
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	83061
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1553849
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	125972
CY2022	dkdcu	Increase Decrease Franchise Tax Payable IncreaseDecreaseFranchiseTaxPayable	-94042
	dkdcu	Increase Decrease Franchise Tax Payable IncreaseDecreaseFranchiseTaxPayable	164008
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	214850
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-940463
CY2022	dkdcu	Amount Deposited Into Trust Account On Execution Of Two One Month Extensions AmountDepositedIntoTrustAccountOnExecutionOfTwoOneMonthExtensions	245840
CY2022	dkdcu	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	2545838
	dkdcu	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	117300000
CY2022	dkdcu	Proceeds From Interest Withdrawn From Trust Account ProceedsFromInterestWithdrawnFromTrustAccount	299601
	dkdcu	Proceeds From Interest Withdrawn From Trust Account ProceedsFromInterestWithdrawnFromTrustAccount	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2246237
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-117300000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000
	dkdcu	Net Proceeds From Initial Public Offering NetProceedsFromInitialPublicOffering	112700000
	dkdcu	Proceeds From Sale Of Private Units ProceedsFromSaleOfPrivateUnits	5852750
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	446112
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	78925
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	78925
CY2022	dkdcu	Advances From Related Parties AdvancesFromRelatedParties	11500
	dkdcu	Advances From Related Parties AdvancesFromRelatedParties	0
CY2022	dkdcu	Proceeds From Working Capital Loan ProceedsFromWorkingCapitalLoan	207081
	dkdcu	Proceeds From Working Capital Loan ProceedsFromWorkingCapitalLoan	0
CY2022	dkdcu	Proceeds From Extension Loan ProceedsFromExtensionLoan	2545838
	dkdcu	Proceeds From Extension Loan ProceedsFromExtensionLoan	0
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2764419
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	118131638
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-422281
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	453151
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	453151
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30870
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	453151
CY2022	dkdcu	Remeasurement Of Class Common Stock Subject To Possible Redemption RemeasurementOfClassCommonStockSubjectToPossibleRedemption	3359593
	dkdcu	Remeasurement Of Class Common Stock Subject To Possible Redemption RemeasurementOfClassCommonStockSubjectToPossibleRedemption	0
CY2022	dkdcu	Redemption Of Class Common Stock Held In Trust Including Interest RedemptionOfClassCommonStockHeldInTrustIncludingInterest	91909483
	dkdcu	Redemption Of Class Common Stock Held In Trust Including Interest RedemptionOfClassCommonStockHeldInTrustIncludingInterest	0
	dkdcu	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	4025000
	dkdcu	Initial Fair Value Of Warrant Liabilities InitialFairValueOfWarrantLiabilities	11176949
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Data Knights Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on February 8, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, the Company had not yet commenced any operations. All activity for the period February 8, 2021 (inception) through December 31, 2022, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), and, since the closing of the initial public offering, the Company has entered into a merger agreement (as described below), and continued a search for a Business Combination candidate. The Company has selected December 31 as its fiscal year end.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company’s Initial Public Offering was declared effective on May 6, 2021. On May 11, 2021, the Company consummated the Initial Public Offering of 11,500,000 units (“Units” and, with respect to the shares of Class A Common Stock included in the Units offered, the “Public Shares”), generating gross proceeds of $115,000,000, which is described in Note 3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 585,275 private placement units (the “Private Placement Units”) at a price of $10.00 per unit in a private placement to the Sponsor, generating gross proceeds of $5,852,750, which is described in Note 4.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering on May 11, 2021, an amount of $117,300,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units was placed in a trust account (“Trust Account”) which may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Transaction costs of the Initial Public Offering amounted to $6,771,112, of which $2,300,000 was for underwriting fees paid at the time of the IPO, $4,025,000 was for deferred underwriting commissions, and $446,112 was for other offering costs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering $959,560 of cash was held outside of the Trust Account available for working capital purposes. As of December 31, 2022, the Company has $30,870 of cash and a working capital deficit of $1,945,267.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On April 25, 2022, the Company, Data Knights Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Data Knights, LLC, the Company’s sponsor (the “Sponsor”), entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with OneMedNet Corporation, Inc., a Delaware corporation (the “Target”, and together with the Company and Merger Sub, the “Parties”) and Paul Casey, as seller representative (“Casey”). Pursuant to the Merger Agreement, upon the closing (the “Closing”) of the Business Combination, the Parties will effect the merger of Merger Sub with and into the Target, with the Target continuing as the surviving entity (the “Merger”), as a result of which all of the issued and outstanding capital stock of the Target shall be exchanged shares of the Class A Common Stock of the Company upon the terms set forth in the Merger Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On May 5, 2022, the Company extended the date by which the Company has to consummate a business combination from May 11, 2022 to August 11, 2022 (the “First Extension”). The First Extension was the first of two three-month extensions permitted under the Company’s governing documents.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 10, 2022, the Company extended the date by which the Company has to consummate a business combination from August 11, 2022 to November 11, 2022 (the “Second Extension”). The Second Extension was the second of two three-month extensions permitted under the Company’s governing documents. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On October 27, 2022, the Company filed a definitive proxy statement with the SEC in connection with the Company’s solicitation of proxies for the vote by the stockholders of the Company at a special meeting of the Company’s stockholders to be held on November 11, 2022 (the “Special Meeting”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On November 11, 2022, at 10:00 a.m. ET, the Company held a virtual special meeting of its stockholders. At the special meeting, Company stockholders entitle to vote at the special meeting cast their votes and approved the Trust Amendment Proposal, pursuant to which the Trust Agreement was amended to extend the date on which Continental must liquidate the Trust Account established in connection with the IPO if the Company has not completed its initial business combination, from November 11, 2022 to August 11, 2023 (or such earlier date after November 11, 2022, as determined by the Data Knights Board). As a part of Special Meeting, the Company’s stockholders approved amendments to its second amended and restated certificate of incorporation (the “Extension Amendment”) and the investment management trust agreement (the “Trust Agreement”) between Continental Stock Transfer & Trust Company, as trustee (“Continental”), and the Company governing the trust account (the “Trust Account”) established in connection with the Company’s initial public offering dated May 11, 2021 (the “Trust Amendment”), which together allow the Company to extend the deadline by which it must complete its initial business combination by up to nine one-month periods. In connection with each such extension, Data Knights, LLC, the Company’s sponsor, shall cause $0.045 per outstanding share of the Company’s Class A Common Stock, or approximately $122,920, to be deposited in the Trust Account. As of December 31, 2022, the Company has executed two one-month extensions, out of the nine, resulting in deposits of approximately $245,840 into the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In connection with the proposed Business Combination with the Target, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Class A Common Stock upon the completion of such Business Combination in connection with a stockholder meeting called to approve such Business Combination. In the event the proposed Business Combination with the Target is not consummated, in connection with an alternative proposed initial business combination, the Company will provide its public stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. In connection with the voting on the Extension Amendment Proposal and the Trust Amendment Proposal at the special meeting, holders of 8,768,456 shares of Class A Common Stock exercised their right to redeem those shares for cash at an approximate price of $10.42 per share, for an aggregate of approximately $91.4 million. Following the payment of the redemptions, the Trust Account had a balance of approximately $28.5 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Based on the above, the Company will have until August 11, 2023 to consummate a Business Combination. If the Company is unable to complete a Business Combination on August 11, 2023 at the election of the Company subject to satisfaction of certain conditions, including the deposit of up $2,300,000 since the underwriters’ over-allotment option is exercised in full ($0.10 per unit), into the Trust Account, or as extended by the Company’s stockholders in accordance with the Company’s amended and restated certificate of incorporation) (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 of interest to pay dissolution expenses), </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). There will be no redemption rights or liquidating distributions with respect to the Founder Shares (as defined below) or the shares of Class A Common Stock and the warrants that are included as components of the Private Placement Units. Such warrants will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.20 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Going Concern, Liquidity and Capital Resources</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, the Company had cash held outside of the Trust Account of $30,780 and $453,151, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete our initial business combination. As of December 31, 2022 and 2021, the Company had working capital surplus (deficit) of $(1,945,267) and $246,232, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s liquidity needs prior to the consummation of its IPO were satisfied through the proceeds of $25,000 from the sale of the Founder Shares and proceed from the promissory note from sponsor of $78,925, which was repaid upon closure of the IPO. Subsequent to the IPO, the Company’s liquidity will be satisfied through a portion of the net proceeds from IPO held outside of the Trust Account. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022 and 2021, we had investments of $29,029,416 and $117,320,973 held in the Trust Account, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes paid and deferred underwriting commissions) to complete our initial business combination. We may withdraw interest to pay taxes. During the period ended December 31, 2022, we withdraw $299,601 of interest earned on the Trust Account to pay Delaware Franchise Tax. During the period ended December 31, 2021, we did not withdraw any interest earned on the Trust Account. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">address this uncertainty during the period leading up to the business combination, however this cannot be guaranteed. The Company will have until August 23, 2023 to consummate a Business Combination. If our initial business combination is not consummated by August 23, 2023, less than one year after the date the financial statements are issued, then our existence will terminate, and we will distribute all amounts in the trust account. The Company intends to complete a business combination before the liquidation date and no adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after such date. There can be no assurance that the Company will be able to consummate an initial business combination by August 23, 2023 and/or have sufficient working capital and borrowing capacity to meet its needs. Based upon the above analysis, management determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Accounts to repay such loaned amounts but no proceeds from our Trust Accounts would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units identical to the Placement Units, at a price of $10.00 per unit at the option of the lender.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Risks and Uncertainties</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into law. The IR Act provides for, among other measures, a new 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from whom the shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased. For purposes of calculating the excise tax, however, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury Department”) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Any redemption or other repurchase effected by us that occurs after December 31, 2022, in connection with a Business Combination or otherwise, may be subject to this excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the nature and amount of any PIPE financing or other equity issuances in connection with the Business Combination (or any other equity issuances within the same taxable year of the Business Combination) and (iii) the content of any regulations and other guidance issued by the Treasury Department and/or the Internal Revenue Service. In addition, because the excise tax would be payable by us and not by the redeeming holder, it could cause a reduction in the value of our stock. The foregoing could cause a reduction in the cash available on hand to complete a business Combination in the required time and redeem 100% of our public shares in accordance with our amended and restated certificate of incorporation) could be subject to the excise tax, in which case the amount that would otherwise be received by our stockholders in connection with our liquidation may be reduced.</p>
CY2021Q1	dkdcu	Condition For Future Business Combination Number Of Businesses Minimum ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum	1
CY2021Q2	dkdcu	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	117300000
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2022Q4	dkdcu	Working Capital Deficit WorkingCapitalDeficit	-1945267
CY2022	dkdcu	Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount	0.80
CY2022	dkdcu	Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination	0.50
CY2022Q2	dkdcu	Number Of Three Month Extensions Permitted For Consummating Initial Business Combination NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination	2
CY2022Q2	dkdcu	Extension Period For Consummating Initial Business Combination ExtensionPeriodForConsummatingInitialBusinessCombination	P3M
CY2022Q3	dkdcu	Number Of Three Month Extensions Permitted For Consummating Initial Business Combination NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination	2
CY2022Q3	dkdcu	Extension Period For Consummating Initial Business Combination ExtensionPeriodForConsummatingInitialBusinessCombination	P3M
CY2022Q4	dkdcu	Number Of One Month Extensions Permitted For Consummating Initial Business Combination NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination	9
CY2022Q4	dkdcu	Extension Period For Consummating Initial Business Combination ExtensionPeriodForConsummatingInitialBusinessCombination	P1M
CY2022Q4	dkdcu	Additional Amount Per Unit Required To Be Deposited In Trust Account AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount	0.045
CY2022Q4	dkdcu	Amount To Be Deposited In Trust Account In Connection With Exercise Of First Monthly Extension AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension	122920
CY2022Q4	dkdcu	Number Of One Month Extensions Executed NumberOfOneMonthExtensionsExecuted	2
CY2022	dkdcu	Extension Period Each Time For Company To Consummate Initial Business Combination ExtensionPeriodEachTimeForCompanyToConsummateInitialBusinessCombination	P1M
CY2022	dkdcu	Number Of One Month Extensions Permitted For Consummating Initial Business Combination NumberOfOneMonthExtensionsPermittedForConsummatingInitialBusinessCombination	9
CY2022Q4	dkdcu	Minimum Net Tangible Asset Upon Consummation Of Business Combination MinimumNetTangibleAssetUponConsummationOfBusinessCombination	5000001
CY2022Q4	dkdcu	Common Stock Holders Exercised Their Right To Redeem Shares For Cash Number Of Shares CommonStockHoldersExercisedTheirRightToRedeemSharesForCashNumberOfShares	8768456
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.42
CY2022Q4	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	91400000
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	28500000
CY2022	dkdcu	Maximum Net Interest To Pay Dissolution Expenses MaximumNetInterestToPayDissolutionExpenses	100000
CY2022Q4	dkdcu	Class Of Warrant Or Right Price Of Warrants Or Rights ClassOfWarrantOrRightPriceOfWarrantsOrRights	10.20
CY2022Q4	dkdcu	Class Of Warrant Or Right Price Of Warrants Or Rights ClassOfWarrantOrRightPriceOfWarrantsOrRights	10.20
CY2022Q4	dkdcu	Cash Held Outside In Trust Account CashHeldOutsideInTrustAccount	30780
CY2021Q4	dkdcu	Cash Held Outside In Trust Account CashHeldOutsideInTrustAccount	453151
CY2022Q4	dkdcu	Working Capital Deficit WorkingCapitalDeficit	-1945267
CY2021Q4	dkdcu	Working Capital Deficit WorkingCapitalDeficit	246232
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	78925
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	29029416
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	117320973
CY2022	dkdcu	Proceeds From Interest Withdrawn From Trust Account ProceedsFromInterestWithdrawnFromTrustAccount	299601
CY2022	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	1500000
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.00
CY2022Q4	dkdcu	Percentage Of Public Shares To Be Redeemed. PercentageOfPublicSharesToBeRedeemed.	1
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2022Q4	us-gaap	Cash Cash	30870
CY2021Q4	us-gaap	Cash Cash	453151
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2021Q4	dkdcu	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	117300000
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2022	dkdcu	Warrant Exercisable WarrantExercisable	12085275
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Concentration of credit risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2022	dkdcu	Extension Period For Consummating Initial Business Combination ExtensionPeriodForConsummatingInitialBusinessCombination	P3M
CY2022	dkdcu	Aggregate Period To Consummate Initial Business Combination AggregatePeriodToConsummateInitialBusinessCombination	P18M
CY2022	dkdcu	Number Of Business Days For Advance Notice Of Extension To Be Given NumberOfBusinessDaysForAdvanceNoticeOfExtensionToBeGiven	5
CY2022	dkdcu	Extension Period For Consummating Initial Business Combination ExtensionPeriodForConsummatingInitialBusinessCombination	P3M
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022	dkdcu	Period From Closing Of Company Initial Public Offering To Consummate Business Combination PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination	P12M
CY2022	dkdcu	Number Of Three Month Extensions Permitted For Consummating Initial Business Combination NumberOfThreeMonthExtensionsPermittedForConsummatingInitialBusinessCombination	2
CY2022	dkdcu	Aggregate Period To Consummate Initial Business Combination AggregatePeriodToConsummateInitialBusinessCombination	P18M
CY2022	dkdcu	Period From Closing Of Company Initial Public Offering To Consummate Business Combination PeriodFromClosingOfCompanyInitialPublicOfferingToConsummateBusinessCombination	P12M
CY2022	dkdcu	Aggregate Period To Consummate Initial Business Combination AggregatePeriodToConsummateInitialBusinessCombination	P18M
CY2022Q4	dkdcu	Extension Period For Consummating Initial Business Combination ExtensionPeriodForConsummatingInitialBusinessCombination	P1M
CY2022Q4	dkdcu	Additional Amount Per Unit Required To Be Deposited In Trust Account AdditionalAmountPerUnitRequiredToBeDepositedInTrustAccount	0.045
CY2022Q4	dkdcu	Amount To Be Deposited In Trust Account In Connection With Exercise Of First Monthly Extension AmountToBeDepositedInTrustAccountInConnectionWithExerciseOfFirstMonthlyExtension	122920
CY2022Q4	dkdcu	Extension Loans Non Current ExtensionLoansNonCurrent	2545838
CY2021Q4	dkdcu	Extension Loans Non Current ExtensionLoansNonCurrent	0
CY2022Q4	dkdcu	Maximum Number Of Demands For Registration Of Securities MaximumNumberOfDemandsForRegistrationOfSecurities	3
CY2022	dkdcu	Underwriting Discount Percentage UnderwritingDiscountPercentage	0.0200
CY2022	dkdcu	Underwriting Discount Paid UnderwritingDiscountPaid	2300000
CY2022	dkdcu	Deferred Underwriting Fees Percentage DeferredUnderwritingFeesPercentage	0.0350
CY2022Q4	dkdcu	Carrying Value As Of Balance Sheet Date Of Deferred Underwriting Commissions Incurred Through That Date And Due After One Year Or Beyond Operating Cycle If Longer. CarryingValueAsOfBalanceSheetDateOfDeferredUnderwritingCommissionsIncurredThroughThatDateAndDueAfterOneYearOrBeyondOperatingCycleIfLonger.	4025000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q1	dkdcu	Fair Value Assets And Liabilities Transfers Between Level1 To Level2 Amount FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount	0
CY2021Q1	dkdcu	Fair Value Assets And Liabilities Transfers Between Level1 To Level2 Amount FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount	0
	dkdcu	Fair Value Assets And Liabilities Transfers Between Level1 To Level2 Amount FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount	0
CY2022	dkdcu	Fair Value Assets And Liabilities Transfers Between Level1 To Level2 Amount FairValueAssetsAndLiabilitiesTransfersBetweenLevel1ToLevel2Amount	0
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	214850
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-715345
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-118531
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	715345
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	118531
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	214850
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	31893
CY2022Q4	dkdcu	Start Up Costs StartUpCosts	833875
CY2021Q4	dkdcu	Start Up Costs StartUpCosts	88493
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	833875
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	120386
CY2021Q4	dkdcu	Unrealized Gain On Investment In Trust Account UnrealizedGainOnInvestmentInTrustAccount	1855
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	833875
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1855
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	833875
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	118531
CY2022Q4	dkdcu	U.S.Federal And State Net Operating Loss U.s.FederalAndStateNetOperatingLoss	0
CY2021Q4	dkdcu	U.S.Federal And State Net Operating Loss U.s.FederalAndStateNetOperatingLoss	162132
CY2022Q4	dkdcu	Limitation On Annual Taxable Income LimitationOnAnnualTaxableIncome	0.80
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	833875
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	118531
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	dkdcu	Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities	-1.7093
	dkdcu	Effective Income Tax Rate Reconciliation Change In Fair Value Of Derivative Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairValueOfDerivativeLiabilities	-0.2589
CY2022	dkdcu	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	0.5918
	dkdcu	Effective Income Tax Rate Reconciliation Transaction Costs Allocated To Warrant Issuance EffectiveIncomeTaxRateReconciliationTransactionCostsAllocatedToWarrantIssuance	0.0257
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1.2971
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0232
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.3896
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0

Files In Submission

Name	View Source	Status
dkdcu-20221231_cal.xml	Edgar Link	unprocessable
0001410578-23-000553-index-headers.html	Edgar Link	pending
0001410578-23-000553-index.html	Edgar Link	pending
0001410578-23-000553.txt	Edgar Link	pending
0001410578-23-000553-xbrl.zip	Edgar Link	pending
dkdcu-20221231.xsd	Edgar Link	pending
dkdcu-20221231x10k.htm	Edgar Link	pending
dkdcu-20221231xex31d1.htm	Edgar Link	pending
dkdcu-20221231xex31d2.htm	Edgar Link	pending
dkdcu-20221231xex32d1.htm	Edgar Link	pending
dkdcu-20221231xex32d2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
dkdcu-20221231_def.xml	Edgar Link	unprocessable
dkdcu-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dkdcu-20221231_pre.xml	Edgar Link	unprocessable
dkdcu-20221231x10k_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONMD
OneMedNet Corp Stock $onmd

2022 Q4 Form 10-K Financial Statement

#000141057823000553 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONMD OneMedNet Corp Stock $onmd

2022 Q4 Form 10-K Financial Statement

#000141057823000553 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONMD
OneMedNet Corp Stock $onmd